A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years

NCT07178522 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

378

Enrollment

INDUSTRY

Sponsor class

Conditions

Enterovirus 71 Inactivated Vaccine

Interventions

BIOLOGICAL: Envacgen®

Sponsor

Medigen Vaccine Biologics Corp.